☆ 4.6 Article

Active surveillance in long period of total neoadjuvant therapy in rectal cancer: Early prediction of poor regression response

FRONTIERS IN ONCOLOGY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Gastroenterology & Hepatology

Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy

Brandon C. Chapman et al.

Summary: The objective of this study was to identify patient and tumor characteristics that predict a complete response following total neoadjuvant therapy. The results showed that over one-third of rectal cancer patients treated with total neoadjuvant therapy can achieve a pathological complete response or sustained clinical complete response with nonoperative management, making oncological resection unnecessary in these patients.

DISEASES OF THE COLON & RECTUM (2023)

添加到收藏夹

Editorial Material Oncology

Is PD-1 Inhibitor Monotherapy a New Standard Treatment for MMR-Deficient Locally Advanced Rectal Cancer?

Eric S. Christenson et al.

Summary: Multimodal treatment courses for locally advanced rectal cancer can lead to significant morbidity. Nonoperative management is feasible for patients who show clinical complete response to neoadjuvant therapies. Recent reports have shown promising results for immunotherapy with checkpoint inhibition in patients with mismatch repair-deficient rectal and colon cancers.

CURRENT ONCOLOGY REPORTS (2022)

添加到收藏夹

Article Immunology

Efficacy and Safety of Neoadjuvant Monoimmunotherapy With PD-1 Inhibitor for dMMR/MSI-H Locally Advanced Colorectal Cancer: A Single-Center Real-World Study

Xuan Zhang et al.

Summary: This study aimed to investigate the effectiveness and safety of single-agent PD-1 inhibitor as neoadjuvant treatment for patients with dMMR/MSI-H LACRC. The results showed favorable objective response rate (ORR) and pathological complete response (pCR) rate, as well as low incidences of immune-related adverse events (irAEs) and surgical-related adverse events (srAEs), indicating the significant effectiveness and safety of this nIT regimen.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Gastroenterology & Hepatology

Impact of total neoadjuvant therapy consisting of consolidation chemotherapy on locally advanced rectal cancer survival

Haoyu Zhang et al.

Summary: This study compared disease-free survival (DFS) and distant metastasis in patients with locally advanced rectal cancer who underwent neoadjuvant chemoradiotherapy (NCRT) or total neoadjuvant therapy (TNT). The results showed that compared to NCRT, TNT achieved a higher pathological complete response (pCR) rate and better 3-year DFS rate and lower distant metastasis rate. NCRT was found to be an independent risk factor for DFS and distant metastasis.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)

添加到收藏夹

Review Pharmacology & Pharmacy

Targeting Akt-associated microRNAs for cancer therapeutics

Mir S. Adil et al.

Summary: miRNAs, a subset of non-coding RNAs, play crucial roles in regulating gene expression in various cellular processes, particularly in cell differentiation, proliferation, apoptosis, and tumorigenesis. They can be modulated using techniques such as miRNA mimics or antagonists and hold potential applications in cancer therapy and early diagnosis. Recent evidence suggests that miRNA-mediated gene regulation intersects with the Akt pathway, forming a regulatory network that may greatly impact cancer therapy.

BIOCHEMICAL PHARMACOLOGY (2021)

添加到收藏夹

Article Oncology

Survival landscape of different tumor regression grades and pathologic complete response in rectal cancer after neoadjuvant therapy based on reconstructed individual patient data

Jia-Yi Li et al.

Summary: The study found that patients with rectal cancer achieving pathologic complete response (pCR) had significantly higher 10-year overall survival and 5-year disease-free survival compared to those in the non-pCR group. Improvement in tumor regression after neoadjuvant therapy was associated with increased overall survival and disease-free survival, and the pCR group had longer overall survival and disease-free survival than the non-pCR group. The results suggest a positive relationship between better tumor regressions and improved survival benefits, highlighting the importance of achieving pCR in the treatment of rectal cancer.

BMC CANCER (2021)

添加到收藏夹

Article Oncology

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Renu R. Bahadoer et al.

Summary: The RAPIDO trial aimed to reduce systemic relapses in locally advanced rectal cancer through short-course radiotherapy, chemotherapy, and delayed surgery. Results showed a decreased probability of disease-related treatment failure in the experimental group compared to standard care, with diarrhea being the most common adverse event and neurological toxicity being prominent in the standard care group during adjuvant chemotherapy.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy et al.

Summary: In patients with cT3 or cT4 M0 rectal cancer, intensifying chemotherapy with FOLFIRINOX before preoperative chemoradiotherapy significantly improved disease-free survival outcomes and reduced neurotoxicity. Thus, the PRODIGE 23 results have the potential to impact clinical practice.

LANCET ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial

F. De Felice et al.

Summary: The study evaluated the efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer, showing promising clinical activity and good tolerance. These findings provide a strong rationale for further phase III studies.

CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Watch-and-wait strategy in rectal cancer: Is there a tumour size limit? Results from two pooled prospective studies

Michal Jankowski et al.

Summary: The frequency and predictive factors for achieving a clinical complete response (cCR) in unselected patients are unclear. Tumor volume and cN status were significant predictors for cCR. The watch-and-wait strategy may not be effective in patients with circular tumors or tumors with a length of 7 cm or more.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Article Pathology

Predictive value of serum and tissue carcinoembryonic antigens for radiologic response and oncologic outcome of rectal cancer

Chang Hyun Kim et al.

PATHOLOGY RESEARCH AND PRACTICE (2020)

添加到收藏夹

Article Oncology

Rectal Cancer, Version 6.2020 Featured Updates to the NCCN Guidelines

Al B. Benson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

添加到收藏夹

Article Gastroenterology & Hepatology

Prognostic value of changes in serum carcinoembryonic antigen levels for preoperative chemoradiotherapy response in locally advanced rectal cancer

Chinock Cheong et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

添加到收藏夹

Article Oncology

Total neoadjuvant approach with FOLFOXIRI plus bevacizumab followed by chemoradiotherapy plus bevacizumab in locally advanced rectal cancer: the TRUST trial

Gianluca Masi et al.

EUROPEAN JOURNAL OF CANCER (2019)

添加到收藏夹

Article Oncology

Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12

Emmanouil Fokas et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

添加到收藏夹

Article Oncology

Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial

Johan Erlandsson et al.

RADIOTHERAPY AND ONCOLOGY (2019)

添加到收藏夹

Review Gastroenterology & Hepatology

Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy

Ri Na Yoo et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2019)

添加到收藏夹

Review Oncology

Rectal Cancer, Version 2.2018 Clinical Practice Guidelines in Oncology

Al B. Benson et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)

添加到收藏夹

Article Oncology

Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer

Andrea Cercek et al.

JAMA ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

添加到收藏夹

Article Oncology

CEA clearance pattern as a predictor of tumor response to neoadjuvant treatment in rectal cancer: a post-hoc analysis of FOWARC trial

Huabin Hu et al.

BMC CANCER (2018)

添加到收藏夹

Review Oncology

Total neoadjuvant therapy for rectal cancer: An emerging option

Ethan B. Ludmir et al.

CANCER (2017)

添加到收藏夹

Review Biochemistry & Molecular Biology

A Review of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Yi Li et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2016)

添加到收藏夹

Article Oncology

Predictors of complete response and Disease recurrence Following chemoradiation for rectal cancer

Danielle S. Bitterman et al.

FRONTIERS IN ONCOLOGY (2015)

添加到收藏夹

Review Gastroenterology & Hepatology

MRI for assessing and predicting response to neoadjuvant treatment in rectal cancer

Regina G. H. Beets-Tan et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)

添加到收藏夹

Article Surgery

Accuracy of Gadofosveset-enhanced MRI for Nodal Staging and Restaging in Rectal Cancer

Doenja M. J. Lambregts et al.

ANNALS OF SURGERY (2011)

添加到收藏夹

Article Oncology

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

Willem van Gijn et al.

LANCET ONCOLOGY (2011)

添加到收藏夹

Article Oncology

Upfront systemic chemotherapy and preoperative short-course radiotherapy with delayed surgery for locally advanced rectal cancer with distant metastases

Sang Joon Shin et al.

RADIATION ONCOLOGY (2011)

添加到收藏夹

Article Surgery

Circumferential resection margin as a prognostic factor in rectal cancer

T. E. Bernstein et al.

BRITISH JOURNAL OF SURGERY (2009)

添加到收藏夹

Article Oncology

Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial

Thierry Andre et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Locally Advanced Rectal Cancer: Added Value of Diffusion-weighted MR Imaging in the Evaluation of Tumor Response to Neoadjuvant Chemo- and Radiation Therapy

Seung Ho Kim et al.

RADIOLOGY (2009)

添加到收藏夹

Article Oncology

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

Morten Braendengen et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer

Sang Min Yoon et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)

添加到收藏夹

Review Oncology

Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy

FM Smith et al.

EJSO (2006)

添加到收藏夹

Article Cell Biology

Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer

R Ryan et al.

HISTOPATHOLOGY (2005)

添加到收藏夹

Article Oncology

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

A de Gramont et al.

JOURNAL OF CLINICAL ONCOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.